XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.52

-22.9%

Dec 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (15960)	8/13/2002 4:23:08 PM
From: Cacaito	Read Replies (1) of 17367

Man, you are so wrong about Biogen, despite their alleged performance the stock is down from $130 to $35. Even from current year highs of $60? to the lows of $29? is not a measure of good performance results from their pr. Survival seems to be more accurate! Your persistence in avoiding Raptiva THREE TRYING TRIALS especially the WEANING one is beyond pale. According to you, a third party created a clinical problem for Raptiva, then the Fda follow on with asking then a trial to solve the third party creation despite the third party having the same problems and not addressing them at all (all the way to approval)and xomaDna drug that does have the problem but xomaDna MUST still comply. Read your own post and that is the essence, I could not believe that you could match, forget about surpasing hiedezjim or moronpolo conspiracies. For Entertainment Purposes Only. All dysclaimers do not apply !!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next